vs
CorMedix Inc.（CRMD）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
CorMedix Inc.的季度营收约是Repay Holdings Corp的1.6倍（$128.6M vs $78.6M），CorMedix Inc.自由现金流更多（$92.7M vs $23.2M）
CorMedix Inc.是一家处于商业阶段的生物制药企业，专注于开发及商业化用于预防和治疗感染性、炎症性及心肾疾病的创新治疗产品，核心管线针对导管相关血流感染，主要服务北美、欧洲的重症监护及长期透析患者群体。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
CRMD vs RPAY — 直观对比
营收规模更大
CRMD
是对方的1.6倍
$78.6M
自由现金流更多
CRMD
多$69.5M
$23.2M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $128.6M | $78.6M |
| 净利润 | — | $-140.1M |
| 毛利率 | 83.4% | 74.2% |
| 营业利润率 | 46.0% | -182.2% |
| 净利率 | — | -178.3% |
| 营收同比 | — | 0.4% |
| 净利润同比 | — | -3304.1% |
| 每股收益（稀释后） | $0.20 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRMDRPAY
| Q4 25 | $128.6M | $78.6M | ||
| Q3 25 | $104.3M | $77.7M | ||
| Q2 25 | $39.7M | $75.6M | ||
| Q1 25 | $39.1M | $77.3M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | — | $79.1M | ||
| Q2 24 | — | $74.9M | ||
| Q1 24 | — | $80.7M |
净利润CRMDRPAY
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $108.6M | $-6.4M | ||
| Q2 25 | $19.8M | $-102.3M | ||
| Q1 25 | $20.6M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | $-5.2M |
毛利率CRMDRPAY
| Q4 25 | 83.4% | 74.2% | ||
| Q3 25 | 89.3% | 74.4% | ||
| Q2 25 | 95.3% | 75.7% | ||
| Q1 25 | 95.9% | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
营业利润率CRMDRPAY
| Q4 25 | 46.0% | -182.2% | ||
| Q3 25 | 49.2% | -3.9% | ||
| Q2 25 | 49.2% | -138.7% | ||
| Q1 25 | 51.5% | -4.7% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -3.1% |
净利率CRMDRPAY
| Q4 25 | — | -178.3% | ||
| Q3 25 | 104.1% | -8.3% | ||
| Q2 25 | 49.9% | -135.2% | ||
| Q1 25 | 52.8% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | -6.5% |
每股收益（稀释后）CRMDRPAY
| Q4 25 | $0.20 | $-1.68 | ||
| Q3 25 | $1.26 | $-0.08 | ||
| Q2 25 | $0.28 | $-1.15 | ||
| Q1 25 | $0.30 | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.5M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $405.3M | $484.4M |
| 总资产 | $826.1M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资CRMDRPAY
| Q4 25 | $148.5M | $115.7M | ||
| Q3 25 | $55.7M | $95.7M | ||
| Q2 25 | $190.7M | $162.6M | ||
| Q1 25 | $77.5M | $165.5M | ||
| Q4 24 | — | $189.5M | ||
| Q3 24 | — | $168.7M | ||
| Q2 24 | — | $147.1M | ||
| Q1 24 | — | $128.3M |
总债务CRMDRPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益CRMDRPAY
| Q4 25 | $405.3M | $484.4M | ||
| Q3 25 | $374.1M | $616.9M | ||
| Q2 25 | $220.6M | $633.7M | ||
| Q1 25 | $114.9M | $755.7M | ||
| Q4 24 | — | $761.3M | ||
| Q3 24 | — | $754.7M | ||
| Q2 24 | — | $815.4M | ||
| Q1 24 | — | $813.8M |
总资产CRMDRPAY
| Q4 25 | $826.1M | $1.2B | ||
| Q3 25 | $750.9M | $1.3B | ||
| Q2 25 | $252.6M | $1.4B | ||
| Q1 25 | $149.6M | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
负债/权益比CRMDRPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.5M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $92.7M | $23.2M |
| 自由现金流率自由现金流/营收 | 72.1% | 29.6% |
| 资本支出强度资本支出/营收 | 1.3% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $172.8M | $90.7M |
8季度趋势，按日历期对齐
经营现金流CRMDRPAY
| Q4 25 | $94.5M | $23.3M | ||
| Q3 25 | $30.9M | $32.2M | ||
| Q2 25 | $30.0M | $33.1M | ||
| Q1 25 | $19.7M | $2.5M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | — | $60.1M | ||
| Q2 24 | — | $31.0M | ||
| Q1 24 | — | $24.8M |
自由现金流CRMDRPAY
| Q4 25 | $92.7M | $23.2M | ||
| Q3 25 | $30.4M | $32.1M | ||
| Q2 25 | $30.0M | $33.0M | ||
| Q1 25 | $19.7M | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率CRMDRPAY
| Q4 25 | 72.1% | 29.6% | ||
| Q3 25 | 29.1% | 41.3% | ||
| Q2 25 | 75.4% | 43.6% | ||
| Q1 25 | 50.5% | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度CRMDRPAY
| Q4 25 | 1.3% | 0.1% | ||
| Q3 25 | 0.5% | 0.2% | ||
| Q2 25 | 0.1% | 0.1% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
现金转化率CRMDRPAY
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
